262 related articles for article (PubMed ID: 29548337)
21. NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers.
Wang X; Yin H; Zhang H; Hu J; Lu H; Li C; Cao M; Yan S; Cai L
Cell Death Dis; 2018 Apr; 9(4):418. PubMed ID: 29549343
[TBL] [Abstract][Full Text] [Related]
22. Reduced EGFR Level in eIF2α PhosphorylationDeficient Hepatocytes Is Responsible for Susceptibility to Oxidative Stress.
Kim MJ; Choi WG; Ahn KJ; Chae IG; Yu R; Back SH
Mol Cells; 2020 Mar; 43(3):264-275. PubMed ID: 32150794
[TBL] [Abstract][Full Text] [Related]
23. Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer.
Pierret T; Toffart AC; Giaj Levra M; Moro-Sibilot D; Gobbini E
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33139612
[TBL] [Abstract][Full Text] [Related]
24. ROS and the DNA damage response in cancer.
Srinivas US; Tan BWQ; Vellayappan BA; Jeyasekharan AD
Redox Biol; 2019 Jul; 25():101084. PubMed ID: 30612957
[TBL] [Abstract][Full Text] [Related]
25. Modulating ROS to overcome multidrug resistance in cancer.
Cui Q; Wang JQ; Assaraf YG; Ren L; Gupta P; Wei L; Ashby CR; Yang DH; Chen ZS
Drug Resist Updat; 2018 Nov; 41():1-25. PubMed ID: 30471641
[TBL] [Abstract][Full Text] [Related]
26. Pseudopterosin Inhibits Proliferation and 3D Invasion in Triple-Negative Breast Cancer by Agonizing Glucocorticoid Receptor Alpha.
Sperlich J; Teusch N
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103404
[TBL] [Abstract][Full Text] [Related]
27. Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation.
Lee JH; Hallis SP; Kwak MK
Arch Pharm Res; 2024 May; 47(5):465-480. PubMed ID: 38734854
[TBL] [Abstract][Full Text] [Related]
28. Roles of reactive oxygen species in inflammation and cancer.
Yu Y; Liu S; Yang L; Song P; Liu Z; Liu X; Yan X; Dong Q
MedComm (2020); 2024 Apr; 5(4):e519. PubMed ID: 38576456
[TBL] [Abstract][Full Text] [Related]
29. DHEA down-regulates mitochondrial dynamics and promotes apoptosis of lung adenocarcinoma cells through FASTKD2.
Zhang YF; Yuan LL; Wang ZC; Zhuang WB; Zhang WJ; Liu HT; Li M; Fan LH
J Cancer; 2024; 15(8):2110-2122. PubMed ID: 38495508
[No Abstract] [Full Text] [Related]
30. The Role of Oxidative Stress in Tumorigenesis and Progression.
Li K; Deng Z; Lei C; Ding X; Li J; Wang C
Cells; 2024 Mar; 13(5):. PubMed ID: 38474405
[TBL] [Abstract][Full Text] [Related]
31. Licochalcone C Inhibits the Growth of Human Colorectal Cancer HCT116 Cells Resistant to Oxaliplatin.
Lee SO; Joo SH; Lee JY; Kwak AW; Kim KT; Cho SS; Yoon G; Choi YH; Park JW; Shim JH
Biomol Ther (Seoul); 2024 Jan; 32(1):104-114. PubMed ID: 38148556
[TBL] [Abstract][Full Text] [Related]
32. Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors.
Kalinkin AI; Sigin VO; Kuznetsova EB; Ignatova EO; Vinogradov II; Vinogradov MI; Vinogradov IY; Zaletaev DV; Nemtsova MV; Kutsev SI; Tanas AS; Strelnikov VV
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139172
[TBL] [Abstract][Full Text] [Related]
33. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy.
Liu J; Han X; Zhang T; Tian K; Li Z; Luo F
J Hematol Oncol; 2023 Nov; 16(1):116. PubMed ID: 38037103
[TBL] [Abstract][Full Text] [Related]
34. Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease.
De Rubis G; Paudel KR; Corrie L; Mehndiratta S; Patel VK; Kumbhar PS; Manjappa AS; Disouza J; Patravale V; Gupta G; Manandhar B; Rajput R; Robinson AK; Reyes RJ; Chakraborty A; Chellappan DK; Singh SK; Oliver BGG; Hansbro PM; Dua K
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2793-2833. PubMed ID: 37991539
[TBL] [Abstract][Full Text] [Related]
35. Licochalcone H Targets EGFR and AKT to Suppress the Growth of Oxaliplatin -Sensitive and -Resistant Colorectal Cancer Cells.
Lee SO; Lee MH; Kwak AW; Lee JY; Yoon G; Joo SH; Choi YH; Park JW; Shim JH
Biomol Ther (Seoul); 2023 Nov; 31(6):661-673. PubMed ID: 37899744
[TBL] [Abstract][Full Text] [Related]
36. β
Del Vecchio V; Mele L; Panda SK; Sanchez-Pajares IR; Mosca L; Tirino V; Barbieri M; Bruzzese F; Luciano A; Marino FZ; Accardo M; Nicoletti GF; Papaccio G; Barbieri A; Desiderio V
Cell Death Dis; 2023 Sep; 14(9):613. PubMed ID: 37723219
[TBL] [Abstract][Full Text] [Related]
37.
Aodah AH; Balaha MF; Jawaid T; Khan MM; Ansari MJ; Alam A
Antibiotics (Basel); 2023 Apr; 12(5):. PubMed ID: 37237738
[No Abstract] [Full Text] [Related]
38. AAZ2 induces mitochondrial-dependent apoptosis by targeting PDK1 in gastric cancer.
Li Y; She W; Xu X; Liu Y; Wang X; Tian S; Li S; Wang M; Yu C; Liu P; Huang T; Wei Y
J Zhejiang Univ Sci B; 2023 Mar; 24(3):232-247. PubMed ID: 36915999
[TBL] [Abstract][Full Text] [Related]
39. ROS is a master regulator of in vitro matriptase activation.
Gaymon DO; Barndt R; Stires H; Riggins RB; Johnson MD
PLoS One; 2023; 18(1):e0267492. PubMed ID: 36716335
[TBL] [Abstract][Full Text] [Related]
40. Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis.
Savic D; Steinbichler TB; Ingruber J; Negro G; Aschenbrenner B; Riechelmann H; Ganswindt U; Skvortsov S; Dudás J; Skvortsova II
Cells; 2023 Jan; 12(2):. PubMed ID: 36672272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
